Patheon buying rival Puerto Rican drug maker

Article Abstract:

Contract drug maker Patheon Inc., is buying rival MOVA Pharmaceuticals Corp. of Puerto Rico for $316-million. The acquisition represents a strategy shift for Mississauga-based Patheon, which has historically purchased excess manufacturing plants from pharmaceutical firms, with contracts in place to continue making the plant's products.

Acquisitions & mergers, Puerto Rico, Mergers, acquisitions and divestments, Company acquisition/merger, MOVA Pharmaceutical Corp.

---

Drug maker Patheon blazes trail

Article Abstract:

Mississauga, Ont.-based Patheon Inc., which is a contract drug manufacturer, is a major supplier of key drugs to the world's top pharmaceutical companies. Patheon reported $418 million in total revenues last year.

Financial management, Finance, Company financing

---

Drug firm Patheon 'disappointed' by third quarter

Article Abstract:

The details on Patheon Inc., which posted a decline in profits for fiscal third quarter, are presented.

Sales, profits & dividends, Company sales and earnings, Company earnings/profit

Similar abstracts:

• Abstracts: Mining stocks, metal prices rise. Iamgold climbs on proposed deal with Gold Fields. Luscar units leap after offer
• Abstracts: Defending Canada's biggest bank machine. Driving a red sports car into bankers' heaven. A man with emotion at the Royal Bank
• Abstracts: T-Mobile USA to start selling new version of BlackBerry. Vancouver firm 'exicted' about sale
• Abstracts: TD takes aim at rivals with major boost to brokerages. Nixon assails insurance rules. Put no limit on mergers or ban all: TD boss
• Abstracts: Independence makes big gains in the boardroom. Changes ease investors' liability fears. Thiessen seeks U.S. audit rules exemption

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.